Regis Logs Wider Net Loss For Q3

Hair salon chain Regis Corporation (RGS) on Tuesday reported net loss of $27.92 million or $0.61 per share in the third quarter, wider than $10.85 million or $0.30 per share loss in the same quarter a year ago, impacted by lower sales.

Excluding one time items, loss was $4.34 million or $0.09 per share.

Revenue for the quarter declined to $64.75 million from $100.27 million last year, driven primarily by the company exiting loss-making, company-owned salons that generated significant revenue.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
Follow RTT